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Oriental cholangiohepatitis, or recurrent pyogenic cholangitis is only noted in certain parts of the world,
especially South East Asia. Due to increasing immigration the disease is now being seen in western
countries also. Treating physicians may face difﬁculty in managing such cases due to lack of exposure.
Furthermore management of such cases is not standardized because of lack of a universally accepted
classiﬁcation system. Here we review the disease and share our long experience with management of
these patients.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Oriental cholangiohepatitis (OCH), an afﬂiction of poverty and
rural environment, is characterized by intrahepatic pigment stones
as the pathophysiological end result of the condition. OCH is
endemic to all countries rimming South China Sea. Improving life
standards account for the decreasing trend of OCH in developing
countries while increasing immigrant population partly accounts
for the rise noticed in developed countries. Etiology of the condi-
tion has been theorized variously but nothing concrete has been
established so far. Clinically it is characterized by repeated attacks
of abdominal pain, fever and jaundice caused by intrahepatic ductal
calculi and strictures [1]. Need for multidisciplinary approach i.e.
integrating interventional radiology, interventional endoscopy and
surgery is agreed world-over but established management pro-
tocols for the condition are yet to surface [2]. In view of its occur-
rence as an evident morbid disease in socioeconomicallying Colony, Sanat Nagar, Sri-
m, fazlparray@gmail.com
by Elsevier Ltd. All rights reservedproductive age group, economic impact of the condition is
immense.2. Incidence
Recurrent pyogenic cholangitis is endemic to South East Asia,
where it was ﬁrst described [3]. In developed countries, though the
disease is rare but it has an increasing trend as is seen in United
Kingdom and United State attributed to increase in immigrant
population [4,5]. The decreasing trend in South East Asia has been
historically attributed to the westernization of developing coun-
tries [6]. However, Park et al. has reported that despite increasing
werternization of Korean life style, the incidence of hepatolithiasis
has remained the same [7]. RPC in India is seen exclusively in
Kashmir as reported by Khuroo et al. [8]3. Etiopathogenesis
In hepatolithiasis bacterial infection via biliary tract is thought
to be the most important step in lithogenesis [9,10]. Escherichia coli
(E. Coli), Klebsiella, Streptococcus and Pseudomonas are the most
frequent isolates from the bile of such patients [9]. ®-Glucuronidase.
F.Q. Parray et al. / International Journal of Surgery 12 (2014) 789e793790from gram negative bacteria, particularly E. coli may be involved in
deconjugation of bilirubin, a process followed by the formation of
calcium-bilirubinate, a major component of brown pigment stones.
Zen Y et al., proposed the possible role of lipopolysaccharide (LP), a
component of gram negative bacteria in aberrant mucin expression
by biliary tree epithelial cells (increased expression of gel-forming
apomucin viz MUC2 and MUC5AC), considered to be important in
the lithogenesis of hepatolithiasis [11].
In addition low protein diet may result in a relative deﬁciency of
glucoro l-4 lactone in the bile [1], with decreased bactericidal and
®-glucuronidase inhibition properties thereby favoring deposition
of pigment stones in the biliary tree [12e14]. Diet low in saturated
fats is also believed to promote bile stasis and so biliary lithogenesis
as it is thought to lack the stimulant for the release of chol-
cystokinin. As majority of the cases of recurrent pyogenic chol-
angitis (RPC) occur at a young age some authorities believe that
congenital anomalies of the ductal system predispose bile stasis
subsequently resulting in stone formation [15]. Presence of lym-
phopenia and reduced CD4 counts in some patients with OCH
suggests the role of some form of immune depression [16].The
suggestion of multi-factorial etiology, with complex interaction of
factors like biliary parasites, enteric pathogens and malnutrition, is
the most plausible explanation for etiopathogenesis in literature at
present.4. Pathology
Probably the dilatation of intra and extrahepatic biliary ducts
with luminal pigment stones, sludge and parasitic, bacterial and
cellular debris constitute the pathological hall mark of OCH. Ductal
wall ﬁbrosis most markedly involves the central major lobar and
segmental ducts. Smaller peripheral ducts appear sharply trun-
cated and cutoff giving the overall picture of “Pruned Tree”. The left
hepatic duct particularly left lateral segmental duct is affectedmore
severely and is involved early in the course of the disease. Left
biliary tree particularly at conﬂuences is more vulnerable to stric-
turous ductal ﬁbrosis [12].5. Management
Difﬁcult access to the parts of biliary tree to which the disease is
commonly distributed and failure to address the yet unknown basic
etiopathogenetic mechanism, adds-up to the quagmire which the
condition poses to the clinician. Integrated use of interventional
endoscopy, interventional radiology and surgery, skillfully tailored
to the thoroughly evaluated individual patient holds the key for
attaining optimal results. A combination of all treatment modal-
ities, on selective basis has been advocated and by using a sys-
tematic approach improvement in treatment results has been
reported for recurrent pyogenic cholangitis [17].
Rate of complete stone clearance by hepatic resection and PTCSL
achieved in such patients has been as high as 84e100% and
72.9e92% respectively [18e24]. Stone recurrence has been re-
ported between 9.5 and 16% of hepatic resection and 32.6e40%
with cholangioscopic lithotomy [23,24]. Complication rates have
been reported to be approximately 12e40% with hepatic resection
and 14.5e22% with Percutaneous transhepatic cholangioscopic li-
thotomy( PTCSL) [19,22,23,25]. Wound infection, subphrenic ab-
scess, bile leakage, cholangitis and sepsis were reported with
hepatic resection, and hemobilia, extreme pain, nausea or vomit-
ing, cholangitis and sepsis with PTCSL. Hemobilia is a serious
complication that can be fatal [18,19,22,23,25,26]. The mortality
rates have been reported at 1.7e3.2% with hepatic resections and
2.1e8% with PTCSL [19,23,25,27].Strategies for patients with bilateral involvement remain
controversial. Hepatic resections are still considered on more
diseased side. In such cases some authors advocate that left sided
hepatectomy should be performed and the stones in right lobe
should be cleared later by cholangioscopic lithotomy through T-
tube tract constructed during surgery or by PTCSL [26,27].
Although intraoperative toilette of remnant liver or transhepatic
clearance could also be done, hepaticojujunal anastomosis (HJA)
with resection of atrophic hepatic segments seems to be the best
option. HJA should also be done in cases with lithiasis affecting both
intra and extrahepatic ducts, as this allows the extrahepatic biliary
system with its strictures to be bypassed, reducing the risk of
recurrent stones. Long term success rates have been achieved by
this operation [28].
Satisfactory results have been reported with liver trans-
plantation in selected patients with intrahepatic stones involving
both lobes with extensive, severe biliary strictures and bilateral
liver atrophy which fail to be treated by other methods [29,30].
Liver transplant seems to be the last choice for OCH with end stage
liver disease, however with modern investigations, imaging and
systematic management few patients if any should reach this stage
of disease.
Extra corporeal shock wave lithotripsy( ESWL) is indicated for
cholesterol hepatolithiasis but pre procedural transhepatic chol-
angioscopic drainage is mandatory for avoiding potential risk of
suppurative cholangitis from stone fragment impation in CBD
[31,32]. Its role in RPC is not well established.
6. Our institutional experience
In the Indian subcontinent ascariasis is highly endemic in
Kashmir (70%), Bangladesh (82%), central and south west India
(20e49%) [33]. A signiﬁcant number of these patients in Kashmir
develop biliary ascariasis. Furthermore up to 5% of these will
progress to develop features of OCH within two years [34]. As such
a signiﬁcant proportion of patients admitted to the departments of
gastroenterology and surgery in Kashmir have OCH. The majority of
these patients need surgery during the progression of the disease
and over the last 26 years the department of surgery has gained
wide experience in the surgical management of the disease. We
have developed and reﬁned our own classiﬁcation system to grade
the patients with OCH who need surgery.
Grade 1 Disease limited to the extrahepatic ducts with stones/
worms, No Liver parenchymal disease, no strictures, and CBD
size less than 1.5 cm.
Grade 2 Disease limited to the extrahepatic ducts with stones/
worms, No liver parenchymal disease, with strictures of CBD, or
CBD size more than 1.5 cm.
Grade 3 Disease involving intrahepatic ducts right or left, with
stones/worms with dilatable strictures and no liver paren-
chymal disease.
Grade 4 Disease involving intrahepatic ducts right or left, with
stones/worms with severe non-dilatable strictures or paren-
chymal disease on same side.
Grade 5 Disease involving both intrahepatic ducts, with stones/
worms with severe non-dilatable strictures or parenchymal
disease on both side.
This classiﬁcation system has allowed us to assess different
surgeries for same grade of disease to determine which one affords
better results. Over a period of many years what we found that with
lesser or conventional surgery most of the patients come back with
recurrent stones and redo surgeries in subsequent sittings are more
difﬁcult and more demanding with worse outcomes. Based on our
Fig. 2. Access Loop to Stomach e an internal access loop of jujenum for future access
to an endoscopist to remove the block; not a very comfortable angle for the endo-
scopist to negotiate.
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various grades of the disease (See Figs. 1e5 for better under-
standing of surgeries). Basic modality of management continues to
be ERCP; however, the following surgeries are only carried on the
patients who are referred to our department after failed ERCP trial
or advanced grades of OCH. MRCP has now been an excellent
addition in the preoperative workup for better understanding the
extent of disease and for better grading and planning for surgery
and even for differentiating benign and malignant obstructions.
[35]
Grade 1 CBD exploration with T Tube drainage.
Grade 2 CBD exploration with Hepaticojejunostomy with or
without access loop
Grade 3 CBD exploration with clearance of intrahepatic stones
and dilatation of strictures with Hepaticojejunostomy with an
access loop.
Grade 4 Liver resections, left lateral sectorectomy, Right or Left
Hepatectomy.
Grade 5 Hepatectomy on more effected side with clearance of
contralateral ducts and dilatation of the strictures and hep-
aticojejunostomy with access loop. Or referral for Liver
transplant.
Patients with grade 1 disease have mild ductal changes so they
are managed as choledocholithiasis, with conﬁrmation of clearance
with choledochoscopy before T Tube drainage. Previously patients
with Stage 2 disease were considered candidates for chol-
edochoduodenostomy but our experience has shown that the CBD
in these patients is ﬁbrotic and does not drainwell so these patients
tend to return with recurrent stones above the anastomosis. To
avoid recurrent surgeries in these patients we prefer to perform a
high biliary enteric anastomosis at the ﬁrst chance. The choice of
access loop in patients with grade 3 disease is decided at the time of
surgery depending on local ﬁndings. We prefer an internal access
loop with the 2nd part of the duodenum in patients being operated
for the ﬁrst time. While in patients who have had previous surgery,
we may occasionally opt for an external access limb as it is tech-
nically easier and avoids difﬁcult dissection in areas with adhe-
sions. Liver resection in our opinion is the best option for patients
with severe strictures and stones impacted proximal to them or for
diseased atrophic liver segments. In our setting this commonlyFig. 1. Permanent Access Hepaticojujenostomy e a closed internal access loop of
jujenum marked with staples put under skin in parietal wall; to be used by an inter-
vention radiologist in case of need to avoid a major surgery.means a left lateral sectorectomy or a left lobectomy and only a few
of our patients require right sided liver resections. Literature also
supports hepatectomy for complex and advanced cases to decrease
the chances of redo surgeries and recurrent stones [36,37]. Patients
with grade 5 disease are most difﬁcult to treat and results are also
dissatisfying. Our choice is usually a liver resection on the worse
affected side with construction of access loop for future manage-
ment of recurrent stones on the contralateral side. However in
patients with severe bilateral involvement and end stage liver we
prefer to refer them for possible liver transplant as the procedure is
not performed at our hospital.Fig. 3. Steigmann's Operation e an internal access loop with proximal duodenum;
again not an endoscopist friendly angle.
Fig. 4. Interposition Hepaticojujenoduodenostomy e a free pedicled internal access
loop of jujenum; time consuming procedure ,not with any signiﬁcant advantage.
F.Q. Parray et al. / International Journal of Surgery 12 (2014) 789e793792The best outcome in patients with OCH can be expected at
advanced tertiary care be achieved by following certain principles;
1. Full preoperative evaluationwith stress both on extent of biliary
tract involvement and liver atrophy.
2. Preoperative counseling of patients about disease with guarded
prognosis and need for recurrent interventions.
3. Referral to experienced center if possible.
4. Selection of most appropriate surgical intervention based on
accepted guidelines.
5. Frequent postoperative chemotherapy to control parasitic
infection.
6. Proper follow up to avoid patients progressing advanced stage of
disease.Fig. 5. Side to side Jujenoduodenal anastamosis e most comfortable internal access
loop in the second part of duodenum; most convenient endoscopist friendly angle to
negotiate; preferred in our set up.Ethical approval
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